Skip to main content

Cannabis stocks mostly higher as sector braces for FDA hearing on rules for CBD

Cannabis stocks were mostly higher Tuesday, as investors braced for a Thursday hearing by the U.S. Food and Drug Administration on how to regulate cannabis and its popular ingredient, CBD.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.